FibroBiologics宣布,其针对恶病质开发的新型成纤维细胞疗法已获得加拿大专利授权。该专利进一步巩固了公司在细胞治疗领域的技术布局与知识产权保护。
FibroBiologics宣布,其针对恶病质开发的新型成纤维细胞疗法已获得加拿大专利授权。该专利进一步巩固了公司在细胞治疗领域的技术布局与知识产权保护。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.